New research sheds light on underlying cause of brain injury in stroke

March 15, 2018

New research shows how the novel drug QNZ-46 can help to lessen the effects of excess release of glutamate in the brain - the main cause of brain injury in stroke.

Published in Nature Communications, the study shows how identifying the source of damaging glutamate in stroke leads to discovery of brain protection with QNZ-46, a novel form of preventative treatment with clinical potential.

Existing studies show that restricted blood supply promotes the excess release of glutamate. The glutamate binds to receptors, over-stimulating them and leading to the break-down of myelin - the protective sheath around the nerve fibre (axon).

Previous studies had focused on the brain's grey matter - the area where all of the synapses operate. Now the new study focuses on white matter - the part of the brain the connects all of the grey matter together - and demonstrates that the glutamate release from axons themselves contributes to damaging myelin.

The study, led by Professor Robert Fern at the Plymouth University Peninsula Schools of Medicine and Dentistry (PUPSMD), is the first direct comparison of vesicular fusion within different cellular components in white matter, and it reveals extensive fusion in axons - a mechanism previously thought to be absent from white matter.

The findings support a rational approach toward a low-impact prophylactic therapy, such as QNZ-46, to protect patients at risk of stroke and other forms of excitotoxic injury (injury caused by excess glutamate).

As stroke is the second leading cause of disability and early death in the UK, Professor Fern, part of the University's Institute of Translational and Stratified Medicine, explains the significance of the findings.

"Strokes are known to be caused by loss of blood to the brain, and there has been no way to treat the condition," he said.

"As much as rehabilitation can be effective, there's nothing you can do to heal the damage. This is why it has been necessary to look at how the problem is caused in the first place.

"Myelin damage results in severe functional deficit in the white matter of the brain, for example in ischemic - caused by lack of blood supply - stroke. By identifying how this happens, we have been able to show how QNZ-46 can be used to prevent the damage.

"There need to be further studies to fully understand how these findings can translate going forward, but to see that there are no negative side effects at this stage is a promising sign. By continuing further studies, we can come up with even better forms of the drug to help in stroke treatment."
-end-
Collaborating with Professor Fern on the study were Sean Doyle, Daniel Bloch Hansen, Peter Bond, Glenn Harper from PUPSMD, and Jasmine Vella, Christian Zammit and Mario Valentino from the University of Malta.

The full study, entitled Vesicular glutamate release from central axons contributes to myelin damage (doi: 10.1038/s41467-018-03427-1) was funded by the University of Plymouth and the Biotechnology and Biological Sciences Research Council, and is available to view in Nature Communications.

University of Plymouth

Related Stroke Articles from Brightsurf:

Stroke alarm clock may streamline and accelerate time-sensitive acute stroke care
An interactive, digital alarm clock may speed emergency stroke care, starting at hospital arrival and through each step of the time-sensitive treatment process.

Stroke patients with COVID-19 have increased inflammation, stroke severity and death
Stroke patients who also have COVID-19 showed increased systemic inflammation, a more serious stroke severity and a much higher rate of death, compared to stroke patients who did not have COVID-19, according a retrospective, observational, cross-sectional study of 60 ischemic stroke patients admitted to UAB Hospital between late March and early May 2020.

'Time is vision' after a stroke
University of Rochester researchers studied stroke patients who experienced vision loss and found that the patients retained some visual abilities immediately after the stroke but these abilities diminished gradually and eventually disappeared permanently after approximately six months.

More stroke awareness, better eating habits may help reduce stroke risk for young adult African-Americans
Young African-Americans are experiencing higher rates of stroke because of health conditions such as high blood pressure, diabetes and obesity, yet their perception of their stroke risk is low.

How to help patients recover after a stroke
The existing approach to brain stimulation for rehabilitation after a stroke does not take into account the diversity of lesions and the individual characteristics of patients' brains.

Kids with headache after stroke might be at risk for another stroke
A new study has found a high incidence of headaches in pediatric stroke survivors and identified a possible association between post-stroke headache and stroke recurrence.

High stroke impact in low- and middle-income countries examined at 11th World Stroke Congress
Less wealthy countries struggle to meet greater need with far fewer resources.

Marijuana use might lead to higher risk of stroke, World Stroke Congress to be told
A five-year study of hospital statistics from the United States shows that the incidence of stroke has risen steadily among marijuana users even though the overall rate of stroke remained constant over the same period.

We need to talk about sexuality after stroke
Stroke survivors and their partners are not adequately supported to deal with changes to their relationships, self-identity, gender roles and intimacy following stroke, according to new research from the University of Sydney.

Standardized stroke protocol can ensure ELVO stroke patients are treated within 60 minutes
A new study shows that developing a standardized stroke protocol of having neurointerventional teams meet suspected emergent large vessel occlusion (ELVO) stroke patients upon their arrival at the hospital achieves a median door-to-recanalization time of less than 60 minutes.

Read More: Stroke News and Stroke Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.
Can't connect to localhost. Errorcode: 1203